Oxygen Biotherapeutics' Common Shares to Begin Trading on the SIX Swiss Exchange June 29, 2010
28. Juni 2010 07:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 28, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) announced today that the company's common stock will begin trading on the Swiss SIX Exchange with...
Oxygen Biotherapeutics Set to Join Russell Microcap Index
25. Juni 2010 07:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 25, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) is set to join the Russell Microcap Index when Russell Investments reconstitutes its comprehensive set of...
Oxygen Biotherapeutics Announces Approval for SIX Swiss Exchange Listing
21. Juni 2010 07:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 21, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in...
Oxygen Biotherapeutics Expands Its Dermacyte(R) Skin Care Sales Territories Into Phoenix and Detroit
10. Juni 2010 09:29 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 10, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced it has expanded the sales territory for its Dermacyte® skin care products into two...
Study Shows Marked Neuroprotective Effects of Oxycyte(R) Perfluorocarbon Emulsion in a Rat Model of Spinal Cord Injury
03. Juni 2010 08:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., June 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today reported on the results of two University of Miami Miller School of Medicine studies involving the...
Oxygen Biotherapeutics Builds New Relationships for Dermacyte Products and Traumatic Brain Injury Clinical Trials
19. Mai 2010 08:45 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., May 19, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced today that the Company has formalized working relationships with an international cosmetic company...
Oxygen Biotherapeutics Hires Sales Director for Skin Care Products
18. Mai 2010 08:45 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., May 18, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced it has hired Jim Weiss to the newly created position of Sales Director. In this...
Oxygen Biotherapeutics Will Not Present at Rodman & Renshaw Global Conference Today as Previously Announced Due to Closed Airports
17. Mai 2010 09:44 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., May 17, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced that the company will not present at the Rodman & Renshaw Global Investment Conference today as...
Oxygen Biotherapeutics CEO to Present at Rodman & Renshaw Global Investment Conference
12. Mai 2010 19:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., May 12, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company will present at the Rodman & Renshaw Global Investment Conference on Monday,...
Oxygen Biotherapeutics, Inc. Announces Registered Direct Offering of $5 Million in Common Stock and Warrants
04. Mai 2010 08:27 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., May 4, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc., a Delaware corporation (Nasdaq:OXBT) (the "Company"), announced today that it entered into purchase agreements with certain...